The Québec Branch of Cochrane Canada is pleased to announce the placement of Dr Alexis Turgeon as Scientific Director. Dr Turgeon is an Associate Professor and Research Director in the Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Meidicine. He practices Critical Care Medicine and Anesthesiology at the CHU de Québec - Hôpital de l’Enfant-Jésus in Québec City. He first graduated from Université Laval medical school in 1999 and, following residency training in Anesthesiology, he completed a master’s degree in Clinical Epidemiology. He pursued training in Critical Care Medicine at the University of Ottawa along with a research fellowship at the Clinical Epidemiology Unit of the Ottawa Hospital Research Institute. He is a Scientist within the Population Health and Optimal Health Practices Research Unit at the CHU de Québec - Université Laval Research Center. Dr Turgeon is an active member of the Canadian Critical Care Trials Group (ccctg).
Alexis Turgeon’s research program focuses on the evaluation of the neurological prognosis in critically ill patients with severe traumatic brain injury and on the comprehension of level of care decisions in neurocritically ill patients. As part of his research program and with colleagues from across Canada, he recently showed a variation in mortality in patients with severe traumatic brain injury across centers in Canada, and a variation in the incidence of withdrawal of life-sustaining therapies.
He currently leads the CIHR-funded TBI-Prognosis Multicenter Prospective Study, a pan-canadian study aiming to develop a prognostic model of long-term prognosis following severe traumatic brain injury. He also leads the FRQS-funded TBI-QualE Study aiming to understand the determinants of the decision to withdraw life-sustaining therapies in critically ill patients with traumatic brain injury. Dr Turgeon his also involved in research on the use of blood products in critically ill patients.
He has a long-time methodological interest and expertise in systematic reviews and meta-analyses. We welcome Dr Turgeon to Cochrane Canada!
